Medtronic (MDT) Tops Q2 Estimates and Raises FY26 Outlook
Medtronic beat Q2 estimates with $9.0 billion in revenue and $1.36 EPS, lifting its full-year guidance.
BTC$65,943.00-0.42%
ETH$1,932.88+0.77%
USDT$0.9994+0.01%
USDC$1.+0.01%
XRP$1.14-0.30%
SOL$77.75-0.13%
TRX$0.3285-0.16%
FIGR_HELOC$1.01+0.34%
HYPE$58.90-3.16%
DOGE$0.0728-0.40%
RAIN$0.0143-5.11%
USDS$0.99990.00%
LEO$9.69-0.25%
ZEC$512.09-3.82%
WBT$57.51-0.20%
BTC$65,943.00-0.42%
ETH$1,932.88+0.77%
USDT$0.9994+0.01%
USDC$1.+0.01%
XRP$1.14-0.30%
SOL$77.75-0.13%
TRX$0.3285-0.16%
FIGR_HELOC$1.01+0.34%
HYPE$58.90-3.16%
DOGE$0.0728-0.40%
RAIN$0.0143-5.11%
USDS$0.99990.00%
LEO$9.69-0.25%
ZEC$512.09-3.82%
WBT$57.51-0.20%
This article provides a comprehensive overview of the latest earnings reports from Medtronic, Genuine Parts Company, and Krystal Biotech, highlighting key performance metrics and future guidance.
Medtronic beat Q2 estimates with $9.0 billion in revenue and $1.36 EPS, lifting its full-year guidance.
Medtronic's Q1 fiscal 2026 results surpassed expectations with an EPS of $1.26 and revenue of $8.6 billion.
Medtronic's fourth-quarter performance exceeded expectations, with notable growth in key segments.
Medtronic plc reported a revenue of $8.29 billion in the third quarter of fiscal year 2025, showing a 2.5% increase as reported and a 4.1% increase…
Medtronic plc (NYSE: MDT) reported a revenue of $8.4 billion for the second quarter of fiscal year 2025.
Medtronic plc (NYSE: MDT) reported a strong first quarter performance for fiscal year 2025, with a revenue of $7.915 billion.
Medtronic plc (NYSE: MDT) reported strong third-quarter fiscal year 2024 results, with revenue of $8.1 billion, surpassing expectations.